On paper, Ozempic (semaglutide) is indicated to help improve glycemic control in adults with type 2 diabetes and reduce risk of cardiovascular events in patients with type 2 diabetes and established cardiovascular disease. Its acclaim in the media and popular culture, however, is much more focused on its corresponding weight loss benefits. Consequently, off-label prescriptions have soared—to the extent that payers are now scrutinizing prescriptions written for patients who are not diabetic. As noted in …
Read More